News Releases

11
May

DRI Healthcare Trust Announces Voting Results of AGM

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) is pleased to announce results of voting at its annual general meeting (“AGM”) of unitholders held on May 11, 2022. All of…

10
May

DRI Healthcare Trust Reports First Quarter 2022 Results

– Continued strong performance of existing assets and financial results – – Completion of Vonjo™ royalty transaction – TORONTO, May 10, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX:…

27
Apr

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust will participate in the following investor conferences in the month of May: Bloom Burton & Co….

27
Apr

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its first quarter 2022 financial results on Wednesday, May 11, 2022, at

20
Apr

DRI Healthcare Trust Announces Upsized Credit Facility

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into an amended and restated credit agreement (the “Amended…

7
Mar

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results

– Announced growth-oriented and accretive transactions of up to $186 million – – Continued strong performance of existing assets and financial results – – Acquired over one million units under…

1
Mar

DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI”) today announced that it has been notified by CTI BioPharma Corp. (“CTI”) that the U.S. Food and Drug Administration (“FDA”) has approved…

22
Feb

DRI Healthcare Trust to Host Fourth Quarter Earnings Call and Webcast on March 8, 2022

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its fourth quarter and full-year 2021 financial results on Tuesday,…

22
Dec

DRI Healthcare Trust Declares Special Distributions

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that its Board of Trustees has declared a special cash distribution in the amount of US$0.22 per trust unit….

30
Nov

DRI Healthcare Trust Comments on Extension of Review Period for pacritinib

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that it has been notified by CTI BioPharma Corp. (CTI) that the U.S. Food and Drug Administration (FDA) has…